Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CNSP
CNSP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CNSP News
CNS Pharmaceuticals Inc. Names Steve O'Loughlin as CFO, Starting March 2 - SEC Filing
Feb 17 2026
moomoo
Webtoon Entertainment Shares Surge 48%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 16 2025
Benzinga
CNS Pharmaceuticals Receives Buy Rating from Maxim Following TPI-287 Development Plan
Sep 13 2025
Yahoo Finance
IBN Unveils New Episode of The BioMedWire Podcast with CNS Pharmaceuticals Inc. CEO John Climaco
Aug 27 2025
Newsfilter
Upcoming Stock Splits This Week (July 21 to July 25) – Stay Invested
Jul 20 2025
TipRanks
CNS Pharmaceuticals Acquires Orphan Drug Designation For TPI 287 And Prices $5M Public Offering
May 13 2025
NASDAQ.COM
CNS Pharmaceuticals files to sell 5.22M shares of common stock, warrants
Apr 14 2025
Business Insider
Maxim Group Downgrades CNS Pharma to Hold
Mar 25 2025
Benzinga
Nasdaq Gains 50 Points; US New Home Sales Rise In February
Mar 25 2025
Benzinga
CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects
Mar 25 2025
Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Mar 19 2025
Benzinga
CNS Pharmaceuticals jumps on current cash position update
Feb 26 2025
SeekingAlpha
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Feb 14 2025
Benzinga
CNS Pharmaceuticals Advances Berubicin and TPI 287 Projects
Jan 03 2025
Business Insider
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Oct 24 2024
Benzinga
Nasdaq Down 2%; US Crude Stocks Increase
Oct 23 2024
Benzinga
Show More News
